Several cancers can directly cause neuropathy, either by physically invading or compressing nerves, or by triggering an immune response that damages the nervous system. The cancers most commonly linked to neuropathy include lung cancer (especially small cell), multiple myeloma, lymphoma, breast cancer, pancreatic cancer, and ovarian cancer. This is separate from chemotherapy-induced neuropathy, which is a side effect of treatment rather than the cancer itself.
How Cancer Causes Nerve Damage
Cancer leads to neuropathy through three main routes. The first is direct physical damage: a tumor grows into or presses against a nerve. The second is an immune-mediated process called a paraneoplastic syndrome, where your immune system produces antibodies to fight the cancer but those antibodies also attack healthy nerve tissue. The third involves abnormal proteins produced by blood cancers that deposit in or around nerves.
These mechanisms can overlap. Someone with lymphoma, for instance, might develop neuropathy from tumor cells directly infiltrating nerves, from immune antibodies gone haywire, or from chemotherapy. Sorting out which mechanism is responsible matters because the treatments differ significantly.
Cancers That Physically Damage Nerves
Solid tumors cause neuropathy when they grow along or into nearby nerve fibers, a process called perineural invasion. This is especially common in cancers of organs that are heavily supplied with nerves. Pancreatic cancer is one of the most notable examples. Cancer cells travel along the nerve sheath, damaging it as they spread, which often produces severe back pain that can be one of the earliest symptoms.
Head and neck cancers frequently invade cranial nerves because of their close anatomical proximity. This can result in facial numbness, tingling, or pain, particularly when the nerve that supplies sensation to the face is affected. Breast cancer can compress or infiltrate the brachial plexus, the network of nerves running from the neck into the arm. This typically causes pain, swelling, and weakness in the affected arm. Notably, tumor-related brachial plexopathy tends to present primarily with pain, while nerve damage from radiation therapy (a common alternative cause in breast cancer survivors) more often starts with tingling and weakness.
Prostate cancer also has a high rate of perineural invasion due to the dense nerve supply surrounding the prostate gland.
Lymphoma and Direct Nerve Infiltration
Lymphoma, particularly B-cell non-Hodgkin lymphoma, can cause a condition called neurolymphomatosis, where lymphoma cells directly invade the peripheral nervous system. This is uncommon but serious. Symptoms vary widely and can include weakness in a single limb, foot drop, pain along nerve roots, or cranial nerve problems. Most cases are painful.
Neurolymphomatosis is notoriously difficult to diagnose because its symptoms mimic many other conditions, including nerve damage from chemotherapy, shingles, or paraneoplastic syndromes. Nerve biopsy detects it about 80% of the time, while standard MRI catches it in only about 40% of cases. PET scans have emerged as a more useful tool when other tests are inconclusive.
Small Cell Lung Cancer and Immune-Mediated Neuropathy
Small cell lung cancer (SCLC) is the cancer most strongly associated with paraneoplastic neurological syndromes. In these conditions, the immune system generates antibodies against the tumor that cross-react with proteins in the nervous system. The result is nerve damage driven not by the tumor itself but by your own immune response.
One well-known example is Lambert-Eaton myasthenic syndrome, where antibodies attack calcium channels at the junction between nerves and muscles. About 3% of SCLC patients develop this syndrome, which causes progressive muscle weakness, typically starting in the legs. The weakness improves temporarily with repeated use of the muscle, which distinguishes it from simple fatigue. Antibodies against these calcium channels are found in roughly 85% of affected patients.
SCLC is also linked to autonomic neuropathy, which affects the nerves controlling involuntary functions like heart rate, blood pressure, digestion, and bladder control. Symptoms can include dizziness on standing, chronic constipation, or difficulty urinating. Paraneoplastic syndromes can appear months before the cancer itself is detected, so unexplained neuropathy sometimes leads to a cancer diagnosis.
Multiple Myeloma and Blood Cancers
Multiple myeloma, a cancer of plasma cells in the bone marrow, causes neuropathy through several mechanisms. The abnormal plasma cells produce large quantities of a single type of antibody protein, and these proteins can deposit in nerve tissue or trigger immune-mediated damage. Between 3% and 20% of newly diagnosed myeloma patients already have neuropathy symptoms before any treatment begins, depending on the study.
A related condition called POEMS syndrome (a constellation of symptoms including nerve damage, organ enlargement, and skin changes) is strongly tied to plasma cell disorders and almost always involves significant peripheral neuropathy. Myeloma can also cause neuropathy through light chain amyloidosis, where fragments of abnormal antibodies accumulate in nerve tissue, or through direct compression of nerve roots when tumors form in the spine.
The picture with myeloma is complicated by the fact that its most effective treatments, particularly certain classes of drugs used as standard therapy, are themselves major causes of neuropathy. This makes it especially important to identify pre-existing nerve damage before treatment starts.
Ovarian, Breast, and Other Cancers
Ovarian cancer is one of the cancers most frequently linked to paraneoplastic neuropathy. Along with breast cancer, testicular cancer, and thymoma (a tumor of the thymus gland), it ranks among the cancers that most commonly trigger immune attacks on the nervous system. Thymoma has a particularly strong association with myasthenia gravis, a condition where antibodies attack the receptors that allow nerves to communicate with muscles, causing fluctuating weakness that worsens with activity.
Breast cancer, lung cancer, Hodgkin lymphoma, and ovarian cancer can also trigger a paraneoplastic condition that damages the cerebellum, the brain region coordinating movement and balance. While this affects the central nervous system rather than peripheral nerves, it produces symptoms that overlap with neuropathy: unsteadiness, difficulty with coordination, and slurred speech.
Cancer-Caused vs. Chemotherapy-Caused Neuropathy
The majority of neuropathy in cancer patients comes from treatment rather than the cancer itself. Around 70% of patients experience some degree of chemotherapy-induced peripheral neuropathy within the first month of treatment, dropping to about 30% at six months or later. Among those who develop it, roughly 41% go on to have chronic nerve pain. Platinum-based drugs and taxanes carry the highest risk, while certain combination regimens have somewhat lower rates.
Chemotherapy-induced neuropathy is typically sensory-predominant, meaning it primarily causes numbness, tingling, and pain rather than muscle weakness. It tends to follow a “stocking-glove” pattern, starting in the fingers and toes and working inward, and is generally dose-related, meaning symptoms worsen with cumulative treatment. It is at least partially reversible in many cases once treatment stops.
Neuropathy caused directly by cancer, by contrast, is more variable. It may affect a single limb or one side of the face rather than following a symmetrical pattern. It can involve motor nerves (causing weakness), sensory nerves (causing pain and numbness), autonomic nerves (causing problems with organ function), or any combination. The pattern and timing of symptoms often provide the first clue about whether the cancer itself or its treatment is responsible. Neuropathy that appears before treatment, affects an unusual distribution of nerves, or comes with severe pain in a specific location is more likely to be cancer-driven.
Which Neuropathy Type Each Cancer Tends to Cause
- Pancreatic cancer: Severe localized pain, often in the back, from perineural invasion
- Head and neck cancers: Facial numbness or pain from cranial nerve involvement
- Breast cancer: Arm pain, weakness, and swelling from brachial plexus compression or infiltration
- Small cell lung cancer: Muscle weakness (Lambert-Eaton syndrome), autonomic dysfunction, or widespread sensory neuropathy
- Multiple myeloma: Symmetric sensory neuropathy in hands and feet, sometimes with autonomic symptoms
- Non-Hodgkin lymphoma: Variable patterns including foot drop, limb weakness, or cranial nerve palsies from direct nerve infiltration
- Ovarian and breast cancer: Paraneoplastic sensory neuropathy or cerebellar dysfunction
- Thymoma: Fluctuating muscle weakness from myasthenia gravis
The overall pattern in cancer-related neuropathy is that sensorimotor polyneuropathies, affecting both sensation and movement, are the most common type. Purely motor neuropathies, purely sensory neuropathies, and autonomic neuropathies all occur but are less frequent. Paraneoplastic causes deserve particular attention in anyone with small cell lung cancer or a lymphoproliferative cancer who develops unexplained nerve symptoms.